Targeted Inhibition of STATs and IRFs as a Potential Treatment Strategy in Cardiovascular Disease

Oncotarget - United States
doi 10.18632/oncotarget.9195
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

2011English

Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation

Frontiers in Immunology
AllergyImmunology
2018English

Inhibition of Hexokinases Holds Potential as Treatment Strategy for Rheumatoid Arthritis

Arthritis Research & Therapy
2019English

Scavenger Receptors and Their Potential as Therapeutic Targets in the Treatment of Cardiovascular Disease

International Journal of Hypertension
Internal Medicine
2010English

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

2012English

Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Inhibition of Phosphodiesterases as a Strategy to Achieve Neuroprotection in Huntington's Disease

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2018English

TheACE2gene: Its Potential as a Functional Candidate for Cardiovascular Disease

Clinical Science
Medicine
2012English

Specific Schistosomiasis Treatment as a Strategy for Disease Control

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy